Inhibition of Delta-protein Kinase C for the Reduction of Infarct Size in Acute Myocardial Infarction
Inhibition of Delta-protein Kinase C for the Reduction of Infarct Size in Acute Myocardial Infarction
The purpose of this study is to determine whether KAI-9803 is safe and effective in reducing infarct size in subjects with ST elevation myocardial infarction (heart attack) undergoing a percutaneous coronary intervention (PCI). A select number of sites will also participate in a substudy where eligible patients will undergo an additional procedure;cardiac magnetic resonance imaging.
Inclusion Criteria:
Exclusion Criteria:
Boxhill, Australia
Victoria, Australia
Kitchner, Ontario, Canada
Toronta, Ontario, Canada
New Brunswick, Canada
Labem, Czechia
BeerSheva, Israel
El Palmar Murcia, Spain
Vigo Pontevedra, Spain